301 related articles for article (PubMed ID: 34360553)
21. Effects of HDAC inhibitors on neuroblastoma SH-SY5Y cell differentiation into mature neurons via the Wnt signaling pathway.
Choi J; Hwang J; Ramalingam M; Jeong HS; Jang S
BMC Neurosci; 2023 May; 24(1):28. PubMed ID: 37127577
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of phosphorylation of TrkB and TrkC and their signal transduction by alpha2-macroglobulin.
Hu YQ; Koo PH
J Neurochem; 1998 Jul; 71(1):213-20. PubMed ID: 9648868
[TBL] [Abstract][Full Text] [Related]
23. Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
Groh T; Hrabeta J; Poljakova J; Eckschlager T; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():16-24. PubMed ID: 23353839
[TBL] [Abstract][Full Text] [Related]
24. Valproic Acid Increases CD133 Positive Cells that Show Low Sensitivity to Cytostatics in Neuroblastoma.
Khalil MA; Hraběta J; Groh T; Procházka P; Doktorová H; Eckschlager T
PLoS One; 2016; 11(9):e0162916. PubMed ID: 27627801
[TBL] [Abstract][Full Text] [Related]
25. Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma.
Poljakova J; Hrebackova J; Dvorakova M; Moserova M; Eckschlager T; Hrabeta J; Göttlicherova M; Kopejtkova B; Frei E; Kizek R; Stiborova M
Neuro Endocrinol Lett; 2011; 32 Suppl 1():101-16. PubMed ID: 22167207
[TBL] [Abstract][Full Text] [Related]
26. Combined valproic acid and celecoxib treatment induced synergistic cytotoxicity and apoptosis in neuroblastoma cells.
Chen Y; Tsai YH; Tseng SH
Anticancer Res; 2011 Jun; 31(6):2231-9. PubMed ID: 21737646
[TBL] [Abstract][Full Text] [Related]
27. Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells.
Stockhausen MT; Sjölund J; Manetopoulos C; Axelson H
Br J Cancer; 2005 Feb; 92(4):751-9. PubMed ID: 15685243
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors.
Tarasenko N; Chekroun-Setti H; Nudelman A; Rephaeli A
J Cell Biochem; 2018 Apr; 119(4):3417-3428. PubMed ID: 29135083
[TBL] [Abstract][Full Text] [Related]
29. Gene expression of TRK neurotrophin receptors in advanced neuroblastomas in Singapore--a pilot study.
Fung W; Hasan MY; Loh AH; Chua JH; Yong MH; Knight L; Hwang WS; Chan MY; Seow WT; Jacobsen AS; Chui CH
Pediatr Hematol Oncol; 2011 Oct; 28(7):571-8. PubMed ID: 21728718
[TBL] [Abstract][Full Text] [Related]
30. The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells.
Cerna T; Hrabeta J; Eckschlager T; Frei E; Schmeiser HH; Arlt VM; Stiborová M
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29304031
[TBL] [Abstract][Full Text] [Related]
31. Acetylcholinesterase gene expression in axotomized rat facial motoneurons is differentially regulated by neurotrophins: correlation with trkB and trkC mRNA levels and isoforms.
Fernandes KJ; Kobayashi NR; Jasmin BJ; Tetzlaff W
J Neurosci; 1998 Dec; 18(23):9936-47. PubMed ID: 9822749
[TBL] [Abstract][Full Text] [Related]
32. Regulation of neurotrophin receptor expression during embryonic and postnatal development.
Escandón E; Soppet D; Rosenthal A; Mendoza-Ramírez JL; Szönyi E; Burton LE; Henderson CE; Parada LF; Nikolics K
J Neurosci; 1994 Apr; 14(4):2054-68. PubMed ID: 8158256
[TBL] [Abstract][Full Text] [Related]
33. Rational basis for Trk inhibition therapy for prostate cancer.
Weeraratna AT; Arnold JT; George DJ; DeMarzo A; Isaacs JT
Prostate; 2000 Oct; 45(2):140-8. PubMed ID: 11027413
[TBL] [Abstract][Full Text] [Related]
34. Genetic evidence for selective neurotrophin 3 signalling through TrkC but not TrkB in vivo.
Stenqvist A; Agerman K; Marmigère F; Minichiello L; Ernfors P
EMBO Rep; 2005 Oct; 6(10):973-8. PubMed ID: 16142215
[TBL] [Abstract][Full Text] [Related]
35. Expression of TrkC in favorable human neuroblastomas.
Yamashiro DJ; Nakagawara A; Ikegaki N; Liu XG; Brodeur GM
Oncogene; 1996 Jan; 12(1):37-41. PubMed ID: 8552397
[TBL] [Abstract][Full Text] [Related]
36. Type I interferons up-regulate the expression and signalling of p75 NTR/TrkA receptor complex in differentiated human SH-SY5Y neuroblastoma cells.
Dedoni S; Olianas MC; Ingianni A; Onali P
Neuropharmacology; 2014 Apr; 79():321-34. PubMed ID: 24333329
[TBL] [Abstract][Full Text] [Related]
37. Dok5 is involved in the signaling pathway of neurotrophin-3 against TrkC-induced apoptosis.
Pan Y; Zhang J; Liu W; Shu P; Yin B; Yuan J; Qiang B; Peng X
Neurosci Lett; 2013 Oct; 553():46-51. PubMed ID: 23954828
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic Regulation of Cytosolic Phospholipase A2 in SH-SY5Y Human Neuroblastoma Cells.
Tan CS; Ng YK; Ong WY
Mol Neurobiol; 2016 Aug; 53(6):3854-3872. PubMed ID: 26162318
[TBL] [Abstract][Full Text] [Related]
39. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
40. Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis.
Rydén M; Sehgal R; Dominici C; Schilling FH; Ibáñez CF; Kogner P
Br J Cancer; 1996 Sep; 74(5):773-9. PubMed ID: 8795581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
